210 (UroAv-81 hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg)
Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate
Pill with imprint 210 is Blue, Capsule-shape and has been identified as UroAv-81 hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg. It is supplied by AvKare, Inc.
UroAv-81 is used in the treatment of urinary tract infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. UroAv-81 hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 210

UroAv-81
- Generic Name
- hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate
- Imprint
- 210
- Strength
- hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg
- Color
- Blue
- Size
- 15.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AvKare, Inc.
- National Drug Code (NDC)
- 42291-0851
- Inactive Ingredients
-
lactose,
polyethylene glycol,
crospovidone,
magnesium stearate,
silicon dioxide,
FD&C Blue No. 1
Note: Inactive ingredients may vary.
Related Images for "210"
More about UroAv-81 (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Side effects
- Drug interactions
- Dosage information
- Imprints, shape & color data
- Drug class: urinary antispasmodics
Patient resources
- Other brands
- Uribel, Uretron DS, Uro-MP, Phosphasal, ... +16 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.